Table 2.
Absolute and relative frequencies of adverse drug reactions (n = 92) detected in the study population
| Adverse drug reactions | n | %a |
|---|---|---|
| Extrapyramidal symptoms | 19 | 20.7 |
| Alterations in blood pressure or heart rate | 14 | 15.2 |
| Electrolyte disturbances | 10 | 10.9 |
| Hypersensitivity reactions | 6 | 6.5 |
| Delirium | 5 | 5.4 |
| Disturbances of salivation | 5 | 5.4 |
| Somnolence | 4 | 4.3 |
| Impairment of renal function and urinary tract-related symptoms | 3 | 3.3 |
| Agitation | 3 | 3.3 |
| Asystole in the context of electroconvulsive therapy | 2 | 2.2 |
| Constipation | 2 | 2.2 |
| Exacerbation of psychotic symptoms | 2 | 2.2 |
| Hallucinations | 2 | 2.2 |
| Blood dyscrasias | 2 | 2.2 |
| Respiratory symptomsb | 2 | 2.2 |
| Intoxication (accidental) | 2 | 2.2 |
| Polyneuropathy | 2 | 2.2 |
| Depression | 1 | 1.1 |
| Disturbance of central thermoregulation | 1 | 1.1 |
| Cognitive dysfunction | 1 | 1.1 |
| Hypothyroidism | 1 | 1.1 |
| Hyperhidrosis | 1 | 1.1 |
| Exacerbation of dysarthrophonia | 1 | 1.1 |
| Other | 1 | 1.1 |
aPercentages may not total 100 due to rounding
bOne respiratory symptom occurred in the context of electroconvulsive therapy